In vitro characterization and in vivo expression of human very-long chain acyl-CoA dehydrogenase

J. Lawrence Merritt, Dietrich Matern, Jerry Vockley, Jan Daniels, Tien V. Nguyen, David B. Schowalter

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency is a disorder of fatty acid beta-oxidation that can present at any age with cardiomyopathy, rhabdomyolysis, hepatic dysfunction, and/or nonketotic hypoglycemia. Through the expansion of newborn screening programs an increasing number of individuals with VLCAD deficiency are being identified prior to the onset of symptoms allowing early initiation of therapy. The development of a safe, durable, and effective VLCAD gene delivery system for use at the time of diagnosis could result in a significant improvement in the quality and duration of life for patients with VLCAD deficiency. To this end, we developed a construct containing the human VLCAD cDNA under the control of the strong CMV promoter (pCMV-hVLCAD). A novel rabbit polyclonal anti-VLCAD antibody was prepared using a 24 amino-acid peptide unique to the human VLCAD protein to study human VLCAD expression in immune competent mice. Antibody specificity was demonstrated in Western blots of human VLCAD deficient fibroblasts and in pCMV-hVLCAD transiently transfected VLCAD deficient fibroblasts. Transfected fibroblasts showed correction of the metabolic block as demonstrated by normalization of C14- and C16-acylcarnitine species in cell culture media and restoration of VLCAD activity in cells. Following tail vein injection of pCMV-hVLCAD into mice, we demonstrated expression of hVLCAD in liver. Altogether, these steps are important in the development of a durable gene therapy for VLCAD deficiency.

Original languageEnglish (US)
Pages (from-to)351-358
Number of pages8
JournalMolecular Genetics and Metabolism
Volume88
Issue number4
DOIs
StatePublished - Aug 1 2006

Keywords

  • Gene therapy
  • Hydrodynamic plasmid injection
  • In vitro correction
  • VLCAD antibody
  • Very-long chain acyl-CoA dehydrogenase

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology

Fingerprint Dive into the research topics of 'In vitro characterization and in vivo expression of human very-long chain acyl-CoA dehydrogenase'. Together they form a unique fingerprint.

  • Cite this

    Merritt, J. L., Matern, D., Vockley, J., Daniels, J., Nguyen, T. V., & Schowalter, D. B. (2006). In vitro characterization and in vivo expression of human very-long chain acyl-CoA dehydrogenase. Molecular Genetics and Metabolism, 88(4), 351-358. https://doi.org/10.1016/j.ymgme.2006.02.010